Karus Therapeutics wins ‘Best Biotech Fundraiser’ award

Oxford, UK, 2 October 2013 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has won ‘Best Biotech Fundraiser’ at this year’s OBN Awards ahead of shortlisted candidates e-Therapeutics and Heptares Therapeutics. The accolade recognised the progress Karus has made in securing US$7 (~£5m) million […]